The, Question

The $775 Million Question: Can Nebius's Order Book Outrun Its Capital Hunger?

Published on 07/28/2026 at 03:02 | Redaktion boerse-global.de

Nebius shares drop 36.7% from record, but 262% yearly gain and $50B order book fuel bull-bear debate amid massive capex plans.

Nebius Stock: $50B Backlog vs $25B Capex Risk Analysis
The $775 Million Question: Can Nebius's Order Book Outrun Its Capital Hunger? Illustration mit AI erstellt ĂĽbermittelt durch boerse-global.de

The numbers tell a story of extremes. Nebius shares have shed 36.7 percent from their June record of €261.00, closing Monday at €165.20 with a barely perceptible 0.15 percent gain. Yet over the past twelve months, the stock has still delivered a staggering 262.28 percent return. This is a stock caught between two powerful forces: a $50 billion order book that would make most cloud companies envious, and a capital expenditure plan that could swallow $25 billion before the next growth phase is complete.

The Backlog That Anchors the Bull Case

The most compelling argument for Nebius's long-term trajectory sits in its contract pipeline. The company has secured nearly $50 billion in customer commitments, anchored by a $27 billion agreement with Meta Platforms and a separate $17.4 billion contract with Microsoft. First-quarter 2026 revenue hit $399 million — a 684 percent surge year-over-year — while adjusted EBITDA reached $129.5 million, marking a clear inflection point in profitability.

This is the foundation that allows management to pursue audacious expansion. A secured $775 million credit line, backed by infrastructure collateral, is funding the global buildout of Nebius's GPU cloud. Projects like the 310-megawatt "AI Factory" in Finland and gigawatt-scale facilities in the United States represent the physical manifestation of that ambition. Nvidia's disclosure of a 9.3 percent passive stake in Nebius, confirmed via a Schedule 13G filing on July 21, sent the stock surging 18.78 percent that day and triggered upgrades from Freedom Capital and Northland Securities.

The Volatility That Haunts the Bear Case

But the same metrics that excite bulls are precisely what worry skeptics. Nebius's annualized 30-day volatility sits at 119.11 percent — a figure that makes the stock unsuitable for anything but the most risk-tolerant portfolios. The shares now trade 16.83 percent below their 50-day moving average, a clear signal that momentum has shifted decisively to the downside. The relative strength index of 42.7 is approaching oversold territory but hasn't yet triggered the capitulation that often precedes a reversal.

Should investors sell immediately? Or is it worth buying Nebius?

The bearish narrative centers on the gap between today's spending and tomorrow's revenue. Nebius has outlined capital expenditure plans of $20 billion to $25 billion, a figure that raises legitimate concerns about dilution and execution risk. Even with a $50 billion backlog, the company must convert those contracts into recognized revenue at a pace that justifies the current market capitalization of €41.91 billion. A May downgrade from DA Davidson, which moved the stock from "Buy" to "Neutral" with a $250 price target, cited valuation rather than any fundamental deterioration — a position that has held through the summer sell-off.

The Meta Factor and Sector-Wide Pressure

The recent slide isn't entirely Nebius-specific. Reports that Meta Platforms plans to commercialize excess AI computing capacity sent a chill through the entire neocloud sector, hitting Nebius and rival CoreWeave alike. This industry-wide reassessment has amplified the stock's existing technical weakness, pushing it 36.7 percent below its June peak and raising questions about whether the correction is a buying opportunity or the beginning of a structural revaluation.

Insider trading filings add another layer of context, though not necessarily alarm. On July 1, a Nebius manager sold 46,627 Class A shares at $235.45 each, part of a broader pattern where three separate filings recorded sales of 97,435 shares at the same price and date. Each transaction was explicitly marked as covering tax withholding obligations from restricted stock unit vesting — routine, non-discretionary moves rather than active bearish bets.

The Technical Crossroads

The chart presents a stock searching for a floor. The 200-day moving average of €121.57 remains the critical long-term support level, and at current prices the shares still trade 35.89 percent above that line. The 50-day average of €198.56, meanwhile, sits well above the current price, confirming the intermediate downtrend. The spread between these two moving averages — roughly €77 — illustrates just how much volatility has compressed into recent weeks.

A stabilization above the 200-day moving average would support the case that this is a consolidation phase rather than a structural breakdown. A break below that level, however, would test the patience of even the most committed bulls. The 52-week low of €43.80 seems distant at current prices, but in a stock with 119 percent annualized volatility, distance can shrink quickly.

Nebius at a turning point? This analysis reveals what investors need to know now.

What Comes Next

The next catalyst is the second-quarter 2026 earnings report, expected in late July though not yet officially confirmed by Nebius. The market will be watching two numbers above all others: the pace of backlog conversion and any revision to the capex guidance. If revenue recognition accelerates without a commensurate increase in spending plans, the path toward the 50-day moving average of €198.56 becomes plausible. If the company raises its capex forecast again without matching revenue projections, pressure toward the 200-day moving average of €121.55 will intensify.

For now, Nebius remains a high-beta bet on the industrialization of artificial intelligence — a story where the operational narrative and the stock price have drifted noticeably apart. The bulls need to prove that the June high was merely a pause in a longer uptrend, not the cycle peak. The evidence, at this moment, is weighted toward the former, but the burden of proof rests squarely on the optimists.

Ad

Nebius Stock: New Analysis - 28 July

Fresh Nebius information released. What's the impact for investors? Our latest independent report examines recent figures and market trends.

Read our updated Nebius analysis...

Disclaimer regarding our articles: No investment advice, no buy or sell recommendation. Information on prices, companies, and markets is provided without guarantee; changes are possible at any time. Stock market transactions can lead to substantial losses. Our articles are created and reviewed in whole or in part automatically with the support of AI.

en | NL0009805522 | THE | boerse | 69888967 |